Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03414450
Title Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors D3 (Drug Discovery and Development), A*STAR Research Entities

chronic myeloid leukemia

acute lymphoblastic leukemia


Dasatinib + ETC-1907206

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Winship Cancer Institute, Emory University Atlanta Georgia 30322 United States Details
The Center for Cancer and Blood Disorders Bethesda Maryland 20874 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Singapore General Hospital Singapore 169608 Singapore Details
*Shaded cells indicate that there was no data available from for the field